Update in Cardiology: Vascular Risk and Cardiac Rehabilitation

被引：0

作者：

Galve, Enrique ^{[1
]}

Castro, Almudena ^{[2
]}

Cordero, Alberto ^{[3
]}

Dalmau, Regina ^{[2
]}

Facila, Lorenzo ^{[4
]}

Garcia-Romero, Aranzazu ^{[5
]}

Mazon, Pilar ^{[6
]}

Sanmartin, Marcelo ^{[7
]}

Alonso Garcia, Angeles ^{[8
]}

机构：

[1] Hosp Valle De Hebron, Serv Cardiol, Barcelona 08035, Spain

[2] Hosp La Paz, Serv Cardiol, Madrid, Spain

[3] Hosp San Juan, Dept Cardiol, Alicante, Spain

[4] Hosp Gen Valencia, Dept Cardiol, Valencia, Spain

[5] Hosp Infanta Elena Rey Juan Carlos, Serv Cardiol, Madrid, Spain

[6] Hosp Santiago de Compostela, Serv Cardiol, Santiago De Compostela, A Coruna, Spain

[7] Hosp Povisa, Serv Cardiol, Vigo, Pontevedra, Spain

[8] Hosp Puerta de Hierro, Serv Cardiol, Madrid, Spain

来源：

REVISTA ESPANOLA DE CARDIOLOGIA | 2013年 / 66卷 / 02期

关键词：

Risk factors; Physical exercise; Cardiac rehabilitation; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; ARTERIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; FAILURE PATIENTS; BLOOD-PRESSURE; TASK-FORCE; EVENTS; BIOMARKERS;

D O I：

10.1016/j.recesp.2012.10.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atherosclerotic cardiovascular disease remains the major cause of premature death in developed and developing countries. Nevertheless, surveys show that most patients still do not achieve the lifestyles, risk factor levels, and therapeutic targets recommended in primary and secondary prevention. The present update reflects the most recent novelties in risk classification and estimation of risk and documents the latest changes in fields such as smoking, diet and nutrition, physical activity, lipids, hypertension, diabetes, and cardiovascular rehabilitation, based on experimental trials and population-based observational studies.

引用

页码：124 / 130

页数：7

共 57 条

[1] Andrés E, 2011, REV ESP CARDIOL, V64, P527, DOI [10.1016/j.recesp.2010.09.012, 10.1016/j.rec.2010.12.003]
[2] Anguita M, 2011, REV ESP CARDIOL, V64, P1090, DOI [10.1016/j.rec.2011.10.006, 10.1016/j.recesp.2011.10.004]
[3] [Anonymous], LANCET
[4] [Anonymous], REV ESP CARDIOL SE
[5] Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond A Presidential Advisory From the American Heart Association
Balady, Gary J.
Ades, Philip A.
Bittner, Vera A.
Franklin, Barry A.
Gordon, Neil F.
Thomas, Randal J.
Tomaselli, Gordon F.
Yancy, Clyde W.
[J]. CIRCULATION, 2011, 124 (25) : 2951 - 2960
[6] Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth A Scientific Statement From the American Heart Association
Balagopal, Prabhakaran
de Ferranti, Sarah D.
Cook, Stephen
Daniels, Stephen R.
Gidding, Samuel S.
Hayman, Laura L.
McCrindle, Brian W.
Mietus-Snyder, Michele L.
Steinberger, Julia
[J]. CIRCULATION, 2011, 123 (23) : 2749 - 2769
[7] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis
Boekholdt, S. Matthijs
Arsenault, Benoit J.
Mora, Samia
Pedersen, Terje R.
LaRosa, John C.
Nestel, Paul J.
Simes, R. John
Durrington, Paul
Hitman, Graham A.
Welch, K. M. A.
DeMicco, David A.
Zwinderman, Aeilko H.
Clearfield, Michael B.
Downs, John R.
Tonkin, Andrew M.
Colhoun, Helen M.
Gotto, Antonio M., Jr.
Ridker, Paul M.
Kastelein, John J. P.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12): : 1302 - 1309
[8] Boyle P, 2012, AM DIAB ASS 2012 SCI
[9] Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials
Braunwald, Eugene
[J]. EUROPEAN HEART JOURNAL, 2012, 33 (04) : 430 - 432
[10] de la Cuerda RC, 2012, REV ESP CARDIOL, V65, P72, DOI [10.1016/j.recesp.2011.07.016, 10.1016/j.rec.2011.07.015]

← 1 2 3 4 5 6 →